Pharma-Bio Serv (PBSV) Profit After Tax (2010 - 2026)
Pharma-Bio Serv posted quarterly Profit After Tax of -$94535.0 for Q1 2026, down 1207.49% year-on-year from $8536.0 in Q1 2025, and down 123.4% on a QoQ basis from $403927.0 in Q4 2025.
Pharma-Bio Serv (PBSV) has 17 years of Profit After Tax data on file, last reported at -$94535.0 in Q1 2026.
- For the quarter ending Q1 2026, Profit After Tax fell 1207.49% year-over-year to -$94535.0; the trailing twelve-month figure through Jan 2026 stood at -$102807.0 (up 68.92% YoY), and the FY2025 full-year result was -$100463.0, up 87.08% from the prior year.
- Profit After Tax for Q1 2026 stood at -$94535.0, down from $403927.0 in the prior quarter.
- Across five years, Profit After Tax topped out at $460466.0 in Q3 2023 and bottomed at -$381782.0 in Q3 2024.
- The 5-year median for Profit After Tax is $240027.0 (2022), against an average of $93686.1.
- The widest annual swing landed in 2024, when Profit After Tax jumped 854.73%; it then plunged 1207.49% in 2026.
- A 5-year view of Profit After Tax shows it stood at $341640.0 in 2022, then sank by 113.8% to -$47148.0 in 2023, then surged by 854.73% to $355838.0 in 2024, then advanced by 13.51% to $403927.0 in 2025, then tumbled by 123.4% to -$94535.0 in 2026.
- The last three Profit After Tax figures came in at -$94535.0 (Q1 2026), $403927.0 (Q4 2025), and -$313877.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | 244.20 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 148.77 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | 69.42 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | 35.13 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | 19.11 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | 43.28 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | -13.47 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | 3.71 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | 11.36 Mn |
| 10 | Pharma-Bio Serv | - | - | 722,374.00 | -94,535.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | -94,535.00 |
| Oct 31, 2025 | 403,927.00 |
| Jul 31, 2025 | -313,877.00 |
| Apr 30, 2025 | -98,322.00 |
| Jan 31, 2025 | 8,536.00 |
| Oct 31, 2024 | 355,838.00 |
| Jul 31, 2024 | -381,782.00 |
| Apr 30, 2024 | -313,375.00 |
| Jan 31, 2024 | -270,719.00 |
| Oct 31, 2023 | -47,148.00 |
| Jul 31, 2023 | 460,466.00 |
| Apr 30, 2023 | 380,078.00 |
| Jan 31, 2023 | 328,632.00 |
| Oct 31, 2022 | 341,640.00 |
| Jul 31, 2022 | 288,034.00 |
| Apr 30, 2022 | 240,027.00 |
| Jan 31, 2022 | 305,244.00 |
| Oct 31, 2021 | -4.87 Mn |
| Jul 31, 2021 | 2.28 Mn |
| Apr 30, 2021 | 240,271.00 |
| Jan 31, 2021 | 268,032.00 |
| Oct 31, 2020 | 144,347.00 |
| Jul 31, 2020 | 692,114.00 |
| Apr 30, 2020 | 687,561.00 |
| Jan 31, 2020 | 526,900.00 |
| Oct 31, 2019 | 477,595.00 |
| Jul 31, 2019 | 431,158.00 |
| Apr 30, 2019 | 707,483.00 |
| Jan 31, 2019 | 471,020.00 |
| Oct 31, 2018 | 3.15 Mn |
| Jul 31, 2018 | 423,714.00 |
| Apr 30, 2018 | -128,348.00 |
| Jan 31, 2018 | -2.66 Mn |
| Oct 31, 2017 | -547,029.00 |
| Jul 31, 2017 | -162,982.00 |
| Apr 30, 2017 | -322,763.00 |
| Jan 31, 2017 | -382,135.00 |
| Oct 31, 2016 | -513,315.00 |
| Jul 31, 2016 | -130,473.00 |
| Apr 30, 2016 | 37,202.00 |
| Jan 31, 2016 | 350,011.00 |
| Oct 31, 2015 | 523,453.00 |
| Jul 31, 2015 | 453,973.00 |
| Apr 30, 2015 | 359,007.00 |
| Jan 31, 2015 | 288,393.00 |
| Jul 31, 2014 | 597,060.00 |
| Apr 30, 2014 | 327,778.00 |
| Jan 31, 2014 | 661,933.00 |
| Oct 31, 2013 | 1.22 Mn |
| Jul 31, 2013 | 1.25 Mn |
| Apr 30, 2013 | 1.39 Mn |
| Jan 31, 2013 | 1.05 Mn |
| Oct 31, 2012 | 1.08 Mn |
| Jul 31, 2012 | 1.28 Mn |
| Apr 30, 2012 | 1.19 Mn |
| Jan 31, 2012 | 1.15 Mn |
| Oct 31, 2011 | 824,427.00 |
| Jul 31, 2011 | 1.50 Mn |
| Apr 30, 2011 | 479,692.00 |
| Jan 31, 2011 | 356,260.00 |
| Oct 31, 2010 | 183,163.00 |
| Jul 31, 2010 | 121,409.00 |